Treatment of OUD in Youth
Pregnancy and OUD
Prescribing Buprenorphine via Telemedicine to Underserved Areas
Translating the Evidence in Addiction to Improve Minority Patient Care in a Culturally-Informed Manner
Post-Traumatic Stress Disorder
Substance Use Disorders and the Intersection with the Justice System: Examining Challenging Cases
Half and Half Waiver Training (New Haven, CT)
This training is being held remotely. To attend please contact Kenneth Morford at [email protected]
How Are Treatment Centers Handling COVID-19?
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
Treating HCV in SUD Patients
PCSS Exchange Session 6 – Implement and Sustain, Part 2
Once we’ve successfully managed the organizational and clinical steps to initiate treatment for patients with OUD, we need to consider how to best sustain this new service and ensure continued access to high-quality care for our most challenging patients. This session will review long-term staffing structure and needs as buprenorphine (or other pharmacotherapies) become part of the treatment landscape in the community. The session will also review the challenges in delivering buprenorphine treatment to a range of patient populations, including those with comorbid mental health and/or physical health conditions, pregnant patients, those with co-occurring pain, and poor responders.
